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Abstract
Background: Fasting and diabetes are characterized by elevated glucocorticoids and reduced
insulin, leptin, elevated hypothalamic AGRP and NPY mRNA, and reduced hypothalamic POMC
mRNA. Although leptin replacement can reverse changes in hypothalamic gene expression
associated with fasting and diabetes, leptin also normalizes corticosterone; therefore the extent to
which the elevated corticosterone contributes to the regulation of hypothalamic gene expression
in fasting and diabetes remains unclear. To address if elevated corticosterone is necessary for
hypothalamic responses to fasting and diabetes, we assessed the effects of adrenalectomy on
hypothalamic gene expression i n  4 8 - h o u r - f a s t e d  o r  d i a b e t i c  m i c e .  T o  a s s e s s  i f  e l e v a t e d
corticosterone is sufficient for the hypothalamic responses to fasting and diabetes, we assessed the
effect of corticosterone pellets implanted for 48 hours on hypothalamic gene expression.
Results: Fasting and streptozotocin-induced diabetes elevated plasma glucocorticoid levels and
reduced serum insulin and leptin levels. Adrenalectomy prevented the rise in plasma
glucocorticoids associated with fasting and diabetes, but not the associated reductions in insulin or
leptin. Adrenalectomy blocked the effects of fasting and diabetes on hypothalamic AGRP, NPY, and
POMC expression. Conversely, corticosterone implants induced both AGRP and POMC mRNA
(with a non-significant trend toward induction of NPY mRNA), accompanied by elevated insulin and
leptin (with no change in food intake or body weight).
Conclusion: These data suggest that elevated plasma corticosterone mediate some effects of
fasting and diabetes on hypothalamic gene expression. Specifically, elevated plasma corticosterone
is necessary for the induction of NPY mRNA with fasting and diabetes; since corticosterone
implants only produced a non-significant trend in NPY mRNA, it remains uncertain if a rise in
corticosterone may be sufficient to induce NPY mRNA. A rise in corticosterone is necessary to
reduce hypothalamic POMC mRNA with fasting and diabetes, but not sufficient for the reduction
of hypothalamic POMC mRNA. Finally, elevated plasma corticosterone is both necessary and
sufficient for the induction of hypothalamic AGRP mRNA with fasting and diabetes.
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Background
Reduction in hypothalamic melanocortin tone, caused by
reduction in proopiomelanocortin (POMC) mRNA and
elevation in agouti-related peptide (AGRP) mRNA, is
thought to play a key role in mediating nutritional effects
on neuroendocrine function [1,2]. Thus fasting [3,4],
insulin deficiency [5], and leptin deficiency [4] are all
associated with reduced hypothalamic melanocortin
tone. However, factors that regulate hypothalamic
melanocortin tone are not fully elucidated. Since both
fasting and insulin deficiency are associated with reduced
plasma leptin [5], and leptin replacement reverses effects
of fasting [6] and also effects of insulin deficiency on food
intake and body weight [7], it has been suggested that the
reduction in leptin accounts for the reduced hypotha-
lamic melanocortin tone in these conditions. However,
fasting can influence hypothalamic gene expression in
insulin-deficient mice independent of changes in plasma
leptin or insulin [5], as well as in leptin resistant db/db
mice [3]. These data suggest that other factors in addition
to leptin may mediate effects of fasting. Since fasting,
insulin deficiency, and leptin insufficiency also lead to an
elevation in plasma glucocorticoids [8], and adrenalec-
tomy of leptin-deficient ob/ob  mice largely normalizes
hypothalamic gene expression in these mice [9], it is plau-
sible that elevated glucocorticoids may mediate some
effects of nutritional state on hypothalamic gene expres-
sion. This hypothesis is particularly compelling since
recent data suggest that aberrant glucocorticoid activity
may play a key role in the development of the metabolic
syndrome [10].
Glucocorticoids have previously been reported to increase
body weight set point, as determined by hoarding behav-
ior in rats [11], while adrenalectomy has been reported to
lower body weight set point in rats [12]. In addition, cen-
tral infusion of glucocorticoids leads to increases in body
weight and food intake with a concomitant induction of
hypothalamic NPY [13]. Nevertheless, it remains unclear
if an elevation in glucocorticoid concentration contrib-
utes to the effect of fasting on hypothalamic gene expres-
sion. Adrenalectomy has been reported to block
elevations in NPY mRNA in response to fasting [14]. On
the other hand, it has been reported that elevation of
plasma corticosterone levels is not required for the induc-
tion of NPY mRNA by fasting [15]. In addition, the extent
to which hypothalamic AGRP and POMC mRNA depends
on elevated glucocorticoid levels in fasting and insulin
deficiency has not been determined to date. Therefore in
the present study we assessed if an elevation of plasma
corticosterone is necessary and sufficient to mediate
effects of fasting and insulin deficiency on hypothalamic
melanocortin tone, as indicated by expression of hypoth-
alamic AGRP and POMC mRNA.
Results and Discussion
Study 1: Effects of adrenalectomy on hypothalamic 
responses to fasting
Fasting reduced body weight and adipose weight in both
the sham-operated and adrenalectomized groups as
expected (Table 1). Blood glucose was also decreased by
fasting in both the sham-operated group and adrenalect-
omized group (Table 1). Serum corticosterone concentra-
tion increased with fasting as expected in the sham-
operated mice (Fig. 1A); adrenalectomy blocked this fast-
ing-induced elevation of corticosterone (Fig. 1A). There-
fore the adrenalectomized fasted mice exhibited similar
levels of corticosterone as both the adrenalectomized ad
lib fed mice and the sham-operated ad lib fed mice (Fig.
1A). As we noted previously, a basal level of corticoster-
one was detectable in the adrenalectomized mice after
surgery [9]. In contrast to corticosterone, other humoral
factors were not significantly affected by adrenalectomy.
Serum insulin and serum leptin both exhibited the same
decreases in the adrenalectomized fasted and sham-oper-
ated fasted animals compared to the adrenalectomized ad
lib fed and sham-operated ad lib fed mice (Fig. 1B and
1C); therefore the levels of these humoral factors were the
same in the sham-operated fasted mice and the adrenalec-
tomized fasted mice.
Fasting increased hypothalamic AGRP mRNA as expected
in the sham-operated fasted group, and adrenalectomy
completely blocked the induction of AGRP by fasting (Fig.
2A). Adrenalectomy also produced a trend to decrease
AGRP mRNA in the ad-lib fed mice but this effect was not
significant (Fig. 2A). Fasting decreased hypothalamic
POMC mRNA as expected in the sham-operated fasted
group, but fasting had no effect on POMC mRNA in the
adrenalectomized animals (Fig. 2B). As with AGRP, NPY
mRNA was also elevated after fasting, and this effect of
fasting on NPY mRNA was also completely blocked by
adrenalectomy (Fig 2C). Adrenalectomy therefore com-
pletely blocked the effects of fasting on hypothalamic
AGRP, POMC and NPY mRNAs.
Study 2: Effects of adrenalectomy on hypothalamic 
responses to insulin deficiency and fasting
Streptozotocin injection induced diabetes in sham-oper-
ated mice (Table 2). Interestingly, adrenalectomy attenu-
ated the rise in blood glucose in streptozotocin-injected
mice (Table 2). Fasting reduced blood glucose in the ADX-
STZ-Fast group below even that of control mice (Table 2).
Streptozotocin injection led to reduced body weight and
adiposity in sham-operated animals as previously
described [5,17] (Table 2), whereas adrenalectomy atten-
uated the loss of both body weight and adiposity associ-
ated with insulin deficiency (Table 2). Streptozotocin
injection also led to significant hyperphagia, typical ofBMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/5
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Effects of fasting on blood hormones in intact and adrenalectomized mice Figure 1
Effects of fasting on blood hormones in intact and adrenalectomized mice. (A) Fasting induces serum corticoster-
one in intact mice but not in adrenalectomized mice. Fasting decreases both serum insulin (B), and serum leptin (C) to the 
same levels in intact and adrenalectomized mice. Data are expressed as mean ± SEM. Groups with different letters are statisti-
cally different (p < 0.05), reflecting ANOVA followed by Tukey-Kramer post hoc tests comparing every group to every other 
group. Thus groups with the same letter do not differ from each other at a p < 0.05 level.
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diabetic mice [17] (Table 2), and adrenalectomy also
ameliorated this response to insulin deficiency (Table 2).
Serum corticosterone was elevated in the Sham-STZ group
and was decreased in both ADX-STZ and ADX-STZ-Fast
groups (Fig. 3A). Adrenalectomy did not result in com-
plete elimination of corticosterone but instead resulted in
low but detectable levels of serum corticosterone as previ-
ously noted [9] and described above. Serum insulin was
reduced to the same extent in Sham-STZ, ADX-STZ, and in
ADX-STZ-Fast groups, compared to control mice, as
would be expected with streptozotocin injection (Fig. 3B).
Serum leptin was also reduced to the same levels in all
experimental groups compared to control mice (Fig. 3C).
Hypothalamic AGRP mRNA was significantly elevated in
sham-operated diabetic (vs. sham-operated euglycemic)
mice as expected [5,17] (Fig. 4A). However, adrenalec-
tomy completely blocked the elevation of AGRP mRNA in
diabetic mice whether or not they were fasted (Fig. 4A).
Hypothalamic POMC mRNA was reduced in diabetic
mice as expected [5,17] (Fig. 4B). Adrenalectomy blocked
this reduction in POMC mRNA in diabetic mice whether
or not they were fasted (Fig. 4B). As with AGRP mRNA,
NPY mRNA was elevated in diabetic mice, and adrenalec-
tomy blocked this induction of NPY mRNA in diabetic
mice whether or not they were fasted (Fig. 4C). In sum-
mary, hypothalamic AGRP, POMC and NPY mRNA all
exhibited the expected changes in association with strep-
tozotocin-induced diabetes [5,17] (Fig. 4A,4B,4C), and
adrenalectomy largely or completely blocked all these
responses to insulin deficiency whether or not the mice
were fasted (Fig 4A,4B,4C).
Study 3: Effects of corticosterone implants on 
hypothalamic gene expression
Implantation of corticosterone implants for 48 hours sig-
nificantly increased serum corticosterone, compared to
placebo-implanted mice, as expected (Fig. 5A). Interest-
ingly, the corticosterone implants also significantly
increased serum insulin and leptin (Fig. 5B and 5C). In
contrast, the corticosterone implants did not significantly
influence body weight or food intake compared to pla-
cebo-implanted mice (body weight of 24.5 ± 0.6 g for the
placebo group compared to 24.4 ± 0.6 g for the corticos-
terone implant group; food intake of 4.3 ± 0.1 g/day for
the placebo group compared to 4.1 ± 0.5 g/day for the cor-
ticosterone implant group), although epididymal adipose
tissue depot was slightly smaller in the corticosterone
implant group (0.19 ± 0.01 g for the placebo group com-
pared to 0.15 ± 0.01 g for the corticosterone implant
group; p < 0.05). Corticosterone implants also had no
influence on blood glucose (134.8 ± 10.9 mg/dl for the
placebo group compared to 128.8 ± 4.3 mg/dl for the cor-
ticosterone implant group).
Implantation of corticosterone implants for 48 hours sig-
nificantly elevated hypothalamic AGRP expression com-
pared to the placebo group (Fig. 6A). Hypothalamic
POMC mRNA was also significantly elevated in the corti-
costerone implant group (Fig. 6B). Hypothalamic NPY
mRNA exhibited a trend toward an increase although the
effect was not significant (p = 0.14; Fig. 6C). Therefore
hypothalamic AGRP and POMC mRNAs were both
induced by the glucocorticoid implant, whereas the NPY
mRNA was not significantly influenced.
Conclusions
In the present study, adrenalectomy and corticosterone
implants were used to address the role of elevated corti-
costerone in mediating the effects of fasting and insulin
deficiency on hypothalamic gene expression, resulting in
several novel observations. First, we have demonstrated
that adrenalectomy can block the elevation of AGRP
mRNA and the reduction in POMC mRNA with fasting,
consistent with previous findings by Ponsalle et al. con-
cerning NPY [14], and suggesting that increases in corti-
costerone mediate fasting-induced changes in
melanocortin tone. Second, we have also shown that
hypothalamic responses to insulin deficiency require ele-
vation in corticosterone. Third, we have demonstrated
using corticosterone implants, that elevated corticoster-
one is sufficient to enhance hypothalamic AGRP expres-
sion, but not to reduce hypothalamic POMC mRNA.
Together these results suggest that an elevation of corticos-
terone is necessary for reduction in melanocortin tone
Table 1: Effects of fasting on body weight, adipose weight and glucose in intact and adrenalectomized mice.
Group n Body weight (g) Adipose weight (g) Blood glucose (mg/dl)
Intact/Ad lib fed 6 22.8 ± 0.8a 0.14 ± 0.04a 108.8 ± 15.1a
Intact/Fasted 6 16.1 ± 0.4b 0.02 ± 0.002b 60.3 ± 4.3b
ADX/Ad lib fed 10 23.6 ± 0.4a 0.22 ± 0.02a 124.1 ± 6.6a
ADX/Fasted 9 19.5 ± 0.7b 0.04 ± 0.006b 52.6 ± 4.8b
Data are expressed as mean ± SEM. Groups with different letters are statistically different (p < 0.05), reflecting ANOVA followed by Tukey-Kramer 
post hoc tests comparing every group to every other group. Thus groups with the same letter do not differ from each other at a p < 0.05 level.BMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/5
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Effects of fasting on hypothalamic gene expression in intact and fasted mice Figure 2
Effects of fasting on hypothalamic gene expression in intact and fasted mice. (A) Hypothalamic AGRP is induced by 
fasting in intact mice however the fasting associated induction is blocked by adrenalectomy. (B) Fasting reduces hypothalamic 
POMC mRNA in intact mice but not in adrenalectomized mice. (C) Similar to AGRP, hypothalamic NPY mRNA is induced in 
intact mice but not in adrenalectomized mice. Data are expressed as mean ± SEM. Groups with different letters are statistically 
different (p < 0.05), reflecting ANOVA followed by Tukey-Kramer post hoc tests comparing every group to every other group. 
Thus groups with the same letter do not differ from each other at a p < 0.05 level.
B.
A.
C.
P
O
M
C
m
R
N
A
(
%
C
o
n
t
r
o
l
)
A
G
R
P
m
R
N
A
(
%
C
o
n
t
r
o
l
)
N
P
Y
m
R
N
A
(
%
C
o
n
t
r
o
l
)
0
0
0
140
500
300 *
*
*
Fed Fast Fed Fast
Intact ADX
100
200
250
50
150
Fed Fast Fed Fast
Intact ADX
Fed Fast Fed Fast
Intact ADX
20
40
60
80
100
120
100
200
300
400BMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/5
Page 6 of 13
(page number not for citation purposes)
during fasting and with diabetes and is sufficient to
induce hypothalamic AGRP mRNA but not to reduce
POMC expression.
Although a reduction in plasma leptin plays an important
role in mediating neuroendocrine responses to fasting [6]
and diabetes [17], we have previously demonstrated that
fasting can regulate hypothalamic melanocortin tone
independently of both leptin and insulin [5]. The present
studies suggest that corticosterone may play a role in
mediating these leptin-independent effects. Fasting was
associated with elevated corticosterone (Fig. 1A) and
reduced insulin and leptin (Fig. 1B and 1C) as well as
melanocortin tone (Fig. 2A and 2B) as expected. However,
preventing the elevation of corticosterone completely
blocked the effect of fasting on hypothalamic AGRP and
POMC mRNA (Fig. 2A and 2B), without preventing effects
of fasting on plasma leptin or insulin. Adrenalectomy also
blocked the effects of fasting on hypothalamic NPY
mRNA (Fig. 2C), confirming the findings of Ponsalle et al.
[14]. These data suggest that leptin's effect to reverse
effects of fasting on melanocortin tone may require and
be mediated by a reduction in glucocorticoids.
Glucocorticoids were also elevated, as expected, in insu-
lin-deficient diabetes (Fig. 3A), and serum insulin, leptin
and melanocortin tone were also reduced in this condi-
tion (Fig. 3B and 3C, 4A and 4B). As with fasting, the
reduction in plasma leptin could largely be a reflection of
the reduction in adipose weight, as well as plasma insulin.
In turn, as with fasting, the reduction of plasma leptin
could be the cause of the elevation of hypothalamic AGRP
and NPY mRNA, as well as the reduction of hypothalamic
POMC mRNA. On the other hand, blocking the rise in
corticosterone by adrenalectomy prevented the reduction
in hypothalamic POMC mRNA and the induction of
AGRP mRNA, without reversing either the reduced leptin
or the reduced adiposity, characteristic of insulin-deficient
diabetic mice (Fig. 4A and 4B). These data suggest that
reversal of effects of insulin deficiency by leptin [7] may
require and be mediated by a reduction in glucocorti-
coids. We had previously shown that fasting could regu-
late hypothalamic gene expression in insulin-deficient
mice even though in these mice fasting did not influence
plasma leptin or insulin [5]. Since adrenalectomy blocked
the fasting-induced reduction in melanocortin tone in
diabetic mice (as it had in euglycemic mice in the first
study), these results suggest that effects of fasting on
melanocortin tone in diabetic mice may be mediated at
least in part by a rise in plasma corticosterone (itself pos-
sibly secondary to the reduction in plasma leptin).
Implanting corticosterone implants for 48 hours led to an
elevation in both hypothalamic AGRP and POMC mRNA
(Fig. 6B). Since adrenalectomy blocked the elevation of
AGRP mRNA by fasting and insulin deficiency, elevation
of corticosterone would be expected to increase hypotha-
lamic AGRP mRNA, as was indeed observed. However, the
corticosterone implants produced the unexpected effect of
elevating hypothalamic POMC mRNA, a rare if not
unique circumstance in which hypothalamic AGRP and
POMC mRNA are regulated in the same direction. The
basis of this unexpected phenomenon is not yet clear.
However, since leptin and insulin both stimulate hypoth-
alamic POMC [18], the elevation of insulin and leptin in
the corticosterone-implanted mice (Fig. 5B and 5C), the
former possibly mediated by glucocorticoid-induced
insulin resistance and the latter possibly mediated by the
resulting hyperinsulinemia, might mediate the observed
effect of corticosterone implants on hypothalamic POMC
in these implanted mice. On the other hand, leptin inhib-
its hypothalamic AGRP mRNA [4], yet AGRP mRNA was
nevertheless elevated in the face of elevated insulin and
leptin. These data suggest that in fasting and insulin-defi-
cient diabetes, as in leptin-deficient ob/ob mice [9,19], glu-
cocorticoids dominate leptin and insulin levels in
determining AGRP expression, whereas insulin and leptin
dominate glucocorticoids in determining hypothalamic
POMC expression. These data are also consistent with the
observation that in streptozotocin-induced diabetic rats,
replacement of insulin is not sufficient to normalize ele-
vated serum corticosterone or the elevated hypothalamic
AGRP mRNA while it does partially normalize plasma
leptin and hypothalamic POMC mRNA [17].
Table 2: Effects of adrenalectomy, diabetes and fasting on body weight, adipose weight, food intake and glucose.
Group n Body weight (g) Adipose weight (g) Food intake (g/day) Glucose (mg/dl)
Control 9 24.3 ± 0.5a 0.20 ± 0.01a 4.3 ± 0.1a 138.1 ± 6.5a
Sham/STZ 8 17.8 ± 0.8b 0.02 ± 0.01b 6.1 ± 0.6b 578.5 ± 17.1b
ADX/STZ 11 21.5 ± 0.9c 0.07 ± 0.02c 4.8 ± 0.1c 368.8 ± 20.4c
ADX/STZ/Fast 5 19.0 ± 0.3b 0.03 ± 0.01c N/A 44.8 ± 13.3d
Data are expressed as mean ± SEM. Groups with different letters are statistically different (p < 0.05), reflecting ANOVA followed by Tukey-Kramer 
post hoc tests comparing every group to every other group. Thus groups with the same letter do not differ from each other at a p < 0.05 level.BMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/5
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Effects of adrenalectomy, streptozotocin injection and fasting on levels of blood hormones Figure 3
Effects of adrenalectomy, streptozotocin injection and fasting on levels of blood hormones. (A) Streptozotocin 
injection elevates levels of serum corticosterone however adrenalectomy prevents the induction associated with streptozo-
tocin. Both serum insulin (B), and serum leptin (C) are reduced to the same extent in all experimental conditions. Data are 
expressed as mean ± SEM. Groups with different letters are statistically different (p < 0.05), reflecting ANOVA followed by 
Tukey-Kramer post hoc tests comparing every group to every other group. Thus groups with the same letter do not differ 
from each other at a p < 0.05 level.
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Effects of adrenalectomy, streptozotocin injection and fasting on levels of hypothalamic gene expression Figure 4
Effects of adrenalectomy, streptozotocin injection and fasting on levels of hypothalamic gene expression. (A) 
Hypothalamic AGRP mRNA is induced by streptozotocin injection, however the induction is partially blocked by adrenalec-
tomy. (B) Hypothalamic POMC mRNA is reduced by streptozotocin injection, but adrenalectomy completely blocks the 
reduction associated with streptozotocin. (C) Similar to AGRP, NPY mRNA is induced by streptozotocin injection and partially 
blocked by adrenalectomy. Data are expressed as mean percentage ± SEM of the control group. Data are expressed as mean ± 
SEM. Groups with different letters are statistically different (p < 0.05), reflecting ANOVA followed by Tukey-Kramer post hoc 
tests comparing every group to every other group. Thus groups with the same letter do not differ from each other at a p < 
0.05 level.
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Effects of corticosterone implants on levels of blood hormones Figure 5
Effects of corticosterone implants on levels of blood hormones. Corticosterone implants elevates levels of serum cor-
ticosterone (A), insulin (B), and leptin (C). Statistical significance was determined by unpaired student's t-test (p < 0.05) and is 
denoted by *.
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Effects of corticosterone implants on hypothalamic gene expression Figure 6
Effects of corticosterone implants on hypothalamic gene expression. Corticosterone implants induces both hypotha-
lamic AGRP (A) and POMC (B) mRNA. (C) NPY mRNA is also elevated by corticosterone implants but the effect did not 
reach statistical significance. Data are expressed as a mean percentage ± SEM of placebo implant group. Statistical significance 
was determined by unpaired student's t-test (p < 0.05) and is denoted by *.
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After the present paper was submitted for review, we
became aware of a recent study by Savontaus et al. exam-
ining the role of glucocorticoids in the regulation of
hypothalamic gene expression in rats [20], using a
roughly similar experimental design as in the present
study. In several respects the conclusions from this study
are similar to the present study (for example, corticoister-
one implants increased hypothalamic AGRP and POMC
mRNA, and adrenalectomy blocked the effect of fasting
on hypothalamic POMC mRNA). However, in one key
respect the results reported by Savontaus et al. differed
from those in the present paper: adrenalectomy failed to
block the effects of fasting on hypothalamic AGRP and
NPY, even though corticosterone implants were observed
to induce AGRP mRNA. Since we observed that adrenalec-
tomy also blocks the effects of diabetes on hypothalamic
gene expression in the present study, we suspect the differ-
ence between the present study and that of Savontaus et
al. is probably due to different regulatory requirements in
mice and rats. For example, it is clear that the regulation
of AGRP differs in rats and mice, since in mice hypotha-
lamic AGRP mRNA is elevated by a deficiency in leptin
receptor function [4] but in rats this is not true [21]. How-
ever, hypothalamic POMC is regulated similarly in rats
and mice, and this is probably the more important ele-
ment regulating metabolic phenotype.
Taken together, these data suggest that elevated glucocor-
ticoids are sufficient to drive the increase in hypothalamic
AGRP mRNA during fasting and diabetes but not the
reduction in POMC mRNA. Interestingly, at least with
respect to food intake and body weight over this 48-hour
period, the elevation of POMC appears to compensate for
the elevation in AGRP to produce no net functional effect
on body weight homeostasis in the presence of
significantly elevated plasma corticosterone. After more
chronic exposure, this delicate balance could plausibly
become disrupted, leading to glucocorticoid-mediated
development of the metabolic syndrome [10]. Thus inter-
actions between insulin, leptin, and glucocorticoids, and
the neuropeptide responses they generate within the
melanocortin system, allow complex metabolic responses
to nutritional status but may also allow the development
of metabolic pathologies.
Methods
Animals
The appropriate Institutional Animal Review Board had
approved all studies.
To study the effect of adrenalectomy on fasting-induced
changes in hypothalamic gene expression (Study 1), two
month-old male C57Bl/6J mice were obtained from The
Jackson Laboratory (Bar Harbor, ME). Mice were individ-
ually housed with free access to food and water under
12:12 h light-dark cycle (lights on at 07:00 h). Of the 31
mice, 19 mice were adrenalectomized and the rest under-
went a sham operation. Adrenalectomy was performed, as
described previously, by bilateral flank incision under
anesthesia (2.5% 2-2-2-tribromoethanol, 0.015–0.017
ml/g body weight, i.p.) [9]. Sham adrenalectomy entailed
the same procedure as adrenalectomy, except that the
adrenal glands were grasped but not removed. After the
surgery all mice were given one injection of dexametha-
sone (45 mg/kg b.w. i.p.) to facilitate recovery from sur-
gery. The drinking water was replaced with normal saline
(0.9% NaCl) to compensate for the loss of mineralocorti-
coids. Body weight was monitored for one week following
the operation at which time it was verified that the ani-
mals had recovered initial body weight as expected. All
mice were placed in fresh cages with new bedding, and
food was removed from half of the adrenalectomized
mice and half of the sham operated mice for 48 hours.
This resulted in four groups; sham ad lib fed (n = 6), sham
48 hour fast (n = 6), adrenalectomized ad lib fed (n = 10)
and adrenalectomized 48 hour fast (n = 9).
To study the effects of adrenalectomy, insulin deficiency
and fasting (Study 2) 33 male C57Bl/6J mice were
obtained at 2 months of age from The Jackson Laboratory
(Bar Harbor, ME) and were individually housed with free
access to feed and water under 12:12 h light-dark cycle as
described above. Mice were treated with daily injections of
dexamethasone (45 mg/kg body weight i.p.) for three
weeks during which time they were either
adrenalectomized or sham operated as described above.
Half the sham-operated and all the adrenalectomized
mice were injected with streptozotocin 10 days after the
surgery (160 mg/kg body weight; freshly purchased from
Sigma, St. Louis, MO and dissolved in 25 mM Citric Acid
Buffer pH = 4.5) while the rest received buffer alone by tail
vein injection 10 days after surgery. Dexamethasone
treatment continued until four days after the streptozo-
tocin injection. Mice were then monitored for two weeks
without the dexamethasone injection at which point half
the adrenalectomized-STZ treated group were fasted while
the rest of the mice were ad lib fed. This resulted in four
separate groups: sham-operated-buffer-injected-ad lib fed
(control; n = 9), sham-operated-streptozotocin-injected-
ad lib fed (sham-STZ; n = 8), adrenalectomized-streptozo-
tocin-injected-ad lib fed (ADX-STZ; n = 11) and adrenal-
ectomized-streptozotocin-injected-fasted mice (ADX-STZ-
Fast; n = 5).
To study the direct effects of corticosterone (Study 3), a
corticosterone implant study was conducted with 16
C57Bl/6J retired breeders also obtained from The Jackson
Laboratories (Bar Harbor, ME). As with the first and sec-
ond studies, mice were individually housed with free
access to food and water under 12:12 h light-dark cycleBMC Physiology 2003, 3 http://www.biomedcentral.com/1472-6793/3/5
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(lights on at 07:00 h). Mice were divided into two group:
one received corticosterone implants of 30 mg (Innova-
tive Research of America, Sarasota, FL) (n = 8), while the
other mice received placebo implants (Innovative
Research of America, Sarasota, FL) (n = 8). Body weight
and food intake were monitored for 48 hours after which
time all the mice were sacrificed.
For all studies, mice were sacrificed following a balanced
design towards the end of the light period (between 17:00
and 18:30 h). Mice were decapitated decapitation after a
brief (approximately 45 second) exposure to carbon diox-
ide; we have verified in pilot studies that the brief expo-
sure to carbon dioxide does not significantly affect the
plasma corticosterone levels under these conditions
(Table 3). Adrenalectomy was verified in each individual
by visual inspection to assure that no visible traces of the
adrenal glands were observed. Brains for Northern blot
analysis were quickly removed and the hypothalamus was
dissected out, frozen on dry ice, and stored at -70°C until
use. Epididymal white adipose tissue was also removed,
weighed, and frozen on dry ice, and stored at -70°C until
use.
Blood chemistry
Blood glucose was measured by a Lifescan One-Touch II
glucose meter (Johnson & Johnson, Mountain View, CA).
Serum insulin and leptin were assayed by an enzyme-
linked immunosorbent assay (ELISA) with commercial
kits (CRYSTAL CHEM INC., Chicago, IL) and serum
corticosterone was assayed by radio immunoassay (RIA)
with commercial kits (ICN Biomedicals Inc., Costa Mesa
CA).
RNA analysis
Total RNA was extracted from tissue using TRIzol (GIBCO
BRL, Gaithersburg, MD). Five micrograms of total RNA
from hypothalamus was subjected to Northern blot anal-
ysis, as described previously, to measure POMC, AGRP
and NPY mRNA [3–5,9]. Seven micrograms of total RNA
from adipose tissue was also subjected to Northern blot
analysis to measure leptin mRNA. The blots were probed
with single-stranded internally labeled DNA probes as
described previously [16]. To monitor RNA loading,
membranes were re-probed and hybridized with a 32P-
labeled probe encoding 18S ribosomal RNA. The total
integrated densities of hybridization signals were deter-
mined by phosphoimager (STORM 860, Molecular
Dynamics, Sunnyvale, CA).
Statistical analysis
For the first study, statistical analysis entailed a two-way
analysis of variance (ANOVA) followed, when indicated
by appropriate p-values (p < 0.05), by Tukey-Kramer post-
hoc test, using the JMP statistical package implemented
on the Macintosh operating system. For the second study
a one-way analysis of variance was performed and
followed, when indicated by appropriate p-values (p <
0.05), by Tukey-Kramer post-hoc test using the JMP statis-
tical package. For the third study unpaired t-tests were car-
ried out using the JMP statistical package. A p-value of less
than 0.05 was considered significant.
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